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Abstract
Elevated plasma concentrations of remnant-like particle cholesterol (RLP-C) are atherogenic. However, factors that
determine RLP-C are not fully understood. This study evaluates which factors affect RLP-C in the fasting and postprandial
state, using multiple regression analyses in a large cohort of lean and obese participants. All participants (n ¼ 740)
underwent a test meal challenge containing 95 energy % (en%) fat (energy content 50% of predicted daily resting
metabolic rate). Fasting and postprandial concentrations of circulating metabolites were measured over a 3-h period.
Obese participants (n ¼ 613) also participated in a 10-wk weight loss program (22510 kJ/d), being randomized to either a
low-fat or a high-fat diet (20–25 vs. 40–45en% fat). Postprandial RLP-C was associated with fasting RLP-C, waist:hip ratio
(WHR), HOMAIR (homeostasis model assessment index for insulin resistance) (P, 0.001), and age, independently of BMI
and gender [adjusted R2 (adj. R2) ¼ 0.70). These factors were also related to fasting RLP-C (P, 0.010), along with gender
and physical activity (adj. R2 ¼ 0.23). The dietary intervention resulted in significantly lower fasting RLP-C concentrations,
independently mediated by weight loss, improvements in HOMAIR, and the fat content of the prescribed diet. However,
after inclusion of plasma triglyceride (TG), HDL-cholesterol, and FFA concentrations in the models, HOMAIR and WHR no
longer significantly predicted fasting RLP-C, although WHR remained a predictor of postprandial RLP-C (P ¼ 0.002).
Plasma TG was strongly associated with both fasting and postprandial RLP-C (P , 0.001). In conclusion, plasma RLP-C
concentrations are mainly associated with plasma TG concentrations. Interestingly, the high-fat diet was more effective at
decreasing fasting RLP-C concentrations in obese participants than the low-fat diet. J. Nutr. 138: 2399–2405, 2008.
Introduction
Insulin-resistant conditions like obesity and type 2 diabetes mellitus
are strongly associated with hyperlipidemia and an increased risk
for atherosclerosis and cardiovascular disease (1). An atherogenic
lipoprotein profile is characterized by high plasma concentrations
of triglyceride (TG)11-rich lipoproteins (TRL), small, dense LDL,
and low plasma concentrations of HDL-cholesterol (HDL-C) (2).
Moreover, high plasma concentrations of remnant-like particles
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(RLP), which are formed when TRL are partly depleted of TG by
lipoprotein lipase, are considered to be highly atherogenic (2,3). In
this context, it has been suggested that plasma RLP-cholesterol
(RLP-C), and not plasma TG, is an independent risk factor for the
development of cardiovascular disease (4–6).
Several studies have been performed to determine which
factors may play a role in RLP metabolism and show associations
with insulin resistance, BMI, upper body obesity, other blood
lipids, gender, and age (7–15). However, most of these studies
were performed in a relatively small number of participants so
that multiple factors could not be taken into account. Moreover,
data on the influence of lifestyle factors such as diet and physical
activity are limited.
Results of a study investigating the effect of dietary compo-
sition on plasma RLP-C suggest that a 2-wk high-carbohydrate
diet [60 energy % (en%) carbohydrate] increased plasma TG
and decreased plasma HDL-C concentrations but also led to
increased fasting and postprandial RLP-C concentrations com-
pared with a 2-wk low-carbohydrate diet (40en% carbohydrate)
(16). On the other hand, it has been shown that reducing the
total fat content of the diet causes weight loss and better weight
maintenance, which can also have a favorable effect on the
blood lipid profile (17). Nevertheless, little information is
available on the relative effects of weight loss and dietary fat
modification on plasma RLP-C concentrations.
The objective of this part of the European multicenter trial
Nutrient-Gene Interactions in Human Obesity–Implications for
Dietary Guidelines (NUGENOB) was to take the drawbacks of
earlier studies into account and investigate the factors that affect
plasma RLP-C concentrations in a large cohort of lean and obese
participants with a detailed phenotype, both in the fasting state
and postprandially after the consumption of a high-fat meal.
Second, we investigated determinants of change in fasting RLP-C
concentration after a 10-wk hypo-energetic diet with either a
high- or low-fat content in the obese participants who partici-
pated in the NUGENOB trial.
Materials and Methods
The study was a randomized, parallel, 2-arm, open-label, 10-wk dietary
intervention of 2 hypo-energetic diets performed in 8 different centers
across 7 European countries: United Kingdom, The Netherlands, France
(2 centers), Spain, Czech Republic, Sweden, and Denmark. The trial was
part of the multicenter EU FP5 project NUGENOB.
Participants. In total, 740 Caucasian participants (552 women) were
included in the NUGENOB study. Inclusion criteria were age 20–50 y,
BMI between 18.5 and 25 kg/m2 for lean participants and BMI $30.0
kg/m2 for obese participants. After baseline measurements, only the
obese participants were allowed to enter the weight loss program.
Details on participant recruitment and exclusion criteria are described
elsewhere (18).
All participants were informed about the nature of the study and gave
written informed consent prior to study participation. The study protocol
was approved by the ethical committee at each of the participating centers.
Experimental design. All participants underwent a 1-d clinical in-
vestigation protocol. Participants arrived at the research center after a 12-h
overnight fast and a preceding 3-d dietary run-in period, during which they
were to keep their habitual diet and avoid excessive physical activity and
alcohol consumption. After the participants voided their bladders, they
underwent anthropometric and body composition assessments [as de-
scribed in Petersen et al. (18)]. Thereafter, participants stayed on a bed for
3.5 h, during which circulating hormones and metabolites were deter-
mined before and after a high-fat test meal. At least 30 min before the start
of the resting measurement, a catheter was inserted in an antecubital
forearm vein for blood sampling. Blood was drawn in the fasting state and
every 60 min following the test meal for the next 3 h. Plasma
concentrations of glucose, insulin, FFA, TG, total cholesterol, HDL-C,
and RLP-C were determined pre- and postprandially. Furthermore,
postprandial RLP-C was also measured 6 h postprandially in a subgroup
of 113 participants to compare 3-h and 6-h RLP-C concentrations. During
the whole experiment, the room was kept thermoneutral at 25C.
The obese participants who participated in the weight loss program
also underwent a second clinical investigation; at the end of the 10-wk
dietary intervention, anthropometric measurements and body composi-
tion assessments were repeated and a venous blood sample was obtained
after an overnight fast.
Test meal. The fluid test meal (double cream with 40% fat/100 g ad-
justed with butter in 2 centers) consisted of 95 en% (percent of total
energy content fat load) fat, 60% of which was saturated fat, 3 en%
carbohydrate, and 2 en% protein. Based on the predicted metabolic rate,
the energy content was fixed at 50% of the predicted basal metabolic rate
(19) and ranged from 1697 to 6590 kJ. Participants were asked to drink
the test meal within 10 min.
Dietary intervention. Stratified block randomization was used with
center, gender, and 3 age groups (20–29, 30–39, and 40–50 y) as strata
and a block size of 12 to assign obese participants to either a low-fat
diet or a high-fat diet. The target macronutrient composition of the low-
fat diet was 20–25% of total energy from fat, 15% from protein, and
60–65% from carbohydrate. The target macronutrient composition of
the high-fat diet was 40–45% of total energy from fat, 15% from
protein, and 40–45% from carbohydrate. Both diets were designed to
provide 2510 kJ/d less than the individually estimated energy require-
ment based on an initial resting metabolic rate multiplied by 1.3.
Information about how the diet was controlled is given in detail
elsewhere (18).
Biochemical analyses. All blood analyses were performed in the
laboratory of one of the centers. Plasma glucose concentrations (ABX
diagnostics), TG (Sigma; ABX diagnostics), and total cholesterol
(cholesterol 100; ABX diagnostics) were measured on a COBAS MIRA
automated spectrophotometric analyzer (Roche Diagnostica). Plasma
FFA (NEFA C kit; Wako Chemicals) and HDL-C (HDL-C Roche) were
measured on a COBAS FARAH centrifugal spectrophotometer (Roche
Diagnostica). Standard samples with known concentrations were included
in each analysis for quality control. Plasma insulin concentrations were
measured with a double antibody RIA (Insulin RIA 100; Kabi-
Pharmacia). RLP-C concentrations were measured in plasma using an
immunoseparation technique developed by Nakajima et al. (20). The
RLP fraction was prepared by mixing 5 mL of plasma with 300 mL
immunoseparation gel suspension, containing a mixture of 2 monoclonal
antibodies, i.e. anti-human apolipoprotein A-I (H-12) and anti-human
apolipoprotein-B-100 (JI-H). The reaction mixture was gently shaken
for 2 h at room temperature on a special mixer (RLP-mixer J100-A,
Photal, Otsuka Electronics). After incubation, 200 mL of supernatant
was used for the measurements of cholesterol (RLP-C) on a COBAS
MIRA S auto-analyzer (ABX diagnostics).
Calculations. The homeostasis model assessment for insulin resistance
(HOMAIR) was calculated from fasting glucose and fasting insulin
according to the equation of Matthews et al. (21). An estimate of total
habitual physical activity was obtained by means of the Baecke
questionnaire using the sum of work, sport, and leisure scores of the
questionnaire (22,23). For comparing postprandial responses, we calcu-
lated the incremental area under the curve (iAUC) according to the
trapezium rule. Postprandial RLP-C is expressed as the plasma concen-
tration of RLP-C at t¼ 180 min, because only baseline and 3-h values of
RLP-C were available.
Statistical methods. Statistical analyses were performed using SPSS
14.0 for Windows (SPSS Inc.). All variables were checked for normal
distribution and non-normally distributed data were ln-transformed to
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satisfy conditions of normality. Student’s t test for unpaired samples was
used to compare participant characteristics at baseline (lean vs. obese,
low- vs. high-fat diet group) and repeated-measures ANOVA was used to
test for differences in time between groups.
Multiple regression analysis was performed to evaluate which factors
were associated with plasma RLP-C concentrations, both in the fasting
state and postprandially after a high-fat meal. The dependent variable in
each multiple regression model was ln-transformed to satisfy conditions
of normality. Independent variables were included in the analyses in
2 steps; gender, BMI, age, HOMAIR, waist:hip ratio (WHR), baseline
dietary fat intake, total physical activity, and/or fasting plasma RLP-C
were included in model 1 and plasma concentrations of TG, FFA, and
HDL-C (fasting or as iAUC in the postprandial model) were included in
model 2.
Determinants of change (D) in fasting RLP-C were also evaluated in 2
models, with the independent variables gender, diet, age, D weight,
D HOMAIR, and D WHR in model 1 and change in fasting plasma TG,
FFA, and HDL-C in model 2. The D was calculated as (10 wk 2 0 wk)
and the models were corrected for the mean values of each D variable (10
wk 1 0 wk/2). Furthermore, all models as described above were
corrected for center (dummy variables) and, in the postprandial model,
for the energy content of the high-fat test meal. To avoid multicollin-
earity, predictors with a correlation . 0.80 were not included in the
model simultaneously. The relative impact of the predictors is demon-
strated as the standardized b-coefficient and its significance value. The
adjusted R2 (adj. R2) of each model is indicated in the tables. Significance
was set at P , 0.05.
Results
At baseline, obese participants had higher plasma concentrations
of RLP-C, TG, FFA, and total cholesterol and a higher HOMAIR
than lean participants (P , 0.001) (Table 1). Furthermore, the
obese participants in the low- and high-fat groups at baseline did
not differ. Fasting plasma RLP-C concentrations decreased in
both groups due to the hypocaloric diet, with a greater reduction
in the high-fat group (20.076 0.01 mmol/L) than in the low-fat
group (20.03 6 0.01 mmol/L; P ¼ 0.019). Also, the decrease in
fasting TG was greater in the high-fat group (20.17 6 0.03
mmol/L) than in the low-fat group (20.03 6 0.02 mmol/L; P ¼
0.007), whereas participants that consumed the low-fat diet had
a greater reduction in plasma total cholesterol and HDL-C
concentrations (Table 1). Dietary goals were achieved in this
study (Table 2) and are, along with the flow of participants in the
NUGENOB study, described in detail elsewhere (18).
After the high-fat meal, plasma RLP-C, TG, and insulin
concentrations increased and there was a postprandial decrease
in plasma FFA concentrations (Fig. 1).
Determinants of fasting RLP-C concentrations. In multiple
regression, HOMAIR, gender, age, WHR, and total physical
activity were positively associated with fasting RLP-C (adj.
R2 ¼ 0.23), with higher concentrations in men than in women
(Table 3). In model 2, fasting TG was the strongest positive
predictor (P , 0.001) for fasting RLP-C concentrations (adj.
R2 ¼ 0.60), whereas the degree of insulin resistance and
WHR were no longer significantly associated with fasting
RLP-C.
Determinants of postprandial RLP-C after a high-fat load.
Fasting RLP-C, HOMAIR, WHR (all P , 0.001), and age (P ¼
0.023) were significantly associated with the plasma RLP-C
response to the high-fat meal (adj. R2 ¼ 0.70) (Table 4). Means
of postprandial RLP-C according to WHR and HOMAIR
quartiles are illustrated in Figure 2. Furthermore, WHR was
still associated with postprandial RLP-C after inclusion of TG,
HDL-C, and FFA iAUC in model 2 (P ¼ 0.002), whereas
HOMAIR was not (P ¼ 0.274). Plasma TG iAUC was strongly
related to postprandial RLP-C (b¼ 0.278; P, 0.001) (adj. R2 ¼
0.76), which was also confirmed in a correlation analysis (Fig. 3).
Plasma concentrations of RLP-C at 3 and 6 h postprandially
were strongly correlated (rs ¼ 0.779; P, 0.001) in a subgroup of
113 participants (data not shown).
Determinants of change in fasting RLP-C after dietary
intervention. Both weight loss and improvement in insulin
resistance were significantly related to a decrease in fasting
RLP-C (adj. R2 ¼ 0.29) after dietary intervention (Table 5).
Furthermore, model 1 confirmed the observation we described
above, i.e. that the high-fat diet was more beneficial than the
low-fat diet in improving RLP-C concentrations in obese partic-
ipants (b¼20.075;P¼ 0.030) and this diet effect was independent
TABLE 1 Participant characteristics at baseline and after a 10-wk hypocaloric diet1
Baseline D after dietary intervention2
Lean Obese Low-fat diet High-fat diet
n 127 (38 M) 613 (150 M) 317 (82 M) 296 (71 M)
Age, y 34 6 1 37 6 0a
BMI, kg/m2 23.8 6 0.3 36.0 6 0.2a 22.5 6 0.1 22.4 6 0.1
WHR 0.81 6 0.01 0.89 6 0.00a 20.02 6 0.00 20.02 6 0.00
HOMAIR 1.11 6 0.06 2.61 6 0.07
a 20.29 6 0.09 20.38 6 0.10
Dietary fat intake, % energy 34.4 6 0.6 36.4 6 0.3a
Total physical activity,3 AU 8.22 6 0.10 7.42 6 0.05a
Fasting metabolites
Plasma RLP-C, mmol/L 0.25 6 0.01 0.33 6 0.01a 20.03 6 0.01 20.07 6 0.01c
Plasma TG, mmol/L 0.74 6 0.03 1.10 6 0.03a 20.03 6 0.02 20.17 6 0.03b
Plasma FFA, mmol/L 418 6 12 520 6 6a 233 6 10 228 6 11
Plasma HDL-C, mmol/L 1.34 6 0.03 1.12 6 0.01a 20.09 6 0.01 20.04 6 0.01b
Plasma total cholesterol, mmol/L 4.59 6 0.08 4.92 6 0.04a 20.37 6 0.04 20.25 6 0.03b
1 Values are means 6 SEM. a P , 0.001, lean vs. obese, Student’s t test for unpaired samples; b P , 0.01; c P , 0.05, diet 3 time
interaction, repeated-measures ANOVA.
2 The change (D) of each value is calculated as (10 wk–baseline).
3 AU, Arbitrary units.
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of the degree of weight loss and the change in insulin resistance. In
model 2, however, these diet and HOMAIR effects disappeared
and a decrease in fasting TG concentrations was the strongest
predictor of a decrease in fasting RLP-C concentrations (adj. R2 ¼
0.51).
Discussion
Elevated plasma concentrations of RLP-C are atherogenic and
have been shown to be an independent risk factor for the
development of cardiovascular disease (5). However, factors that
are associated with plasma RLP-C concentrations are not fully
understood. This study demonstrates that both fasting and
postprandial plasma RLP-C are strongly related to HOMAIR and
WHR, which is consistent with earlier indications from the
literature (7–11,24,25). When adding plasma TG, FFA, and
HDL-C to the models, however, plasma TG was the strongest
predictor of both fasting and postprandial RLP-C, and in the
fasting model, the associations with HOMAIR and WHR were no
longer significant. It has been shown before in a study in obese
children that fasting RLP-C was significantly associated with
systolic blood pressure and HOMAIR, whereas only TG was
associated with RLP-C after inclusion of other lipids in the model
(7). This may be due to the high correlation between plasma RLP-
C and plasma TG, which is not surprising, because a large part of
plasma TG is carried in TRL and RLP particles. It may well be
that although RLP represent the more atherogenic fraction,
measuring RLP-C is not necessary to assess this risk, because
plasma TG mirrors plasma RLP-C.
Men had significantly higher fasting RLP-C concentrations
than women and RLP-C concentrations increased with age,
which is consistent with previous findings (14,26). In the post-
prandial response to the high-fat meal, however, the gender
effects on plasma RLP-C were explained by the effect of body fat
distribution; WHR was significantly associated with postpran-
dial RLP-C, independent of gender, BMI, the degree of insulin
resistance, and postprandial circulating TG concentrations,
suggesting that body fat distribution is directly linked to RLP-
C in the postprandial phase. Abdominal obesity plays an
important role in postprandial TRL metabolism in both men
and women (13,27). Based on our results, the association
between WHR and postprandial RLP-C seems to be stronger
than the association with gender.
The postprandial response after the high-fat meal was
measured over a 3-h period, which is a relatively short time
for studying postprandial lipid profiles. Therefore, we analyzed
RLP-C concentrations 6 h postprandially in a subgroup of the
TABLE 2 Composition of the habitual diet of lean and obese
participants at baseline and the composition of the
low- and high-fat hypocaloric intervention diets in
obese participants1,2
Habitual diet Low-fat diet High-fat diet
n 740 3023 2853
Energy intake, kJ/d 9118 6 103 6518 6 88 6846 6 85a
Fat, % energy 36.1 6 0.3 25.1 6 0.3 41.3 6 0.3a
Carbohydrate, % energy 45.8 6 0.3 56.6 6 0.3 41.5 6 0.3a
Protein, % energy 16.3 6 0.1 17.8 6 0.2 17.0 6 0.2a
Alcohol, % energy 1.8 6 0.1 0.4 6 0.1 0.2 6 0.1b
Dietary fiber, g/d 18.5 6 0.3 22.6 6 0.4 19.1 6 0.4a
1 Values are means 6 SEM. a P , 0.01; b P , 0.05, low-fat vs. high-fat diet, Student’s
t test for unpaired samples.
2 The composition of the diets is based on a 3-d-weighed food record.
3 A small number of participants did not complete a 3-d-weighed food record after the
10-wk dietary intervention period.
FIGURE 1 Plasma concentrations of RLP-C (A), HDL-C (B), FFA (C), TG (D), glucose (E), and insulin (F) during fasting (t ¼ 0) and after
consumption of a high-fat meal according to BMI categories: BMI ,25 kg/m2 (d) (n ¼ 92), BMI 25–30 kg/m2 (s) (n ¼ 35), BMI 30–35 kg/m2 (:)
(n ¼ 294), BMI 35–40 kg/m2 (n) (n ¼ 185), and BMI .40 kg/m2 (n) (n ¼ 106). Values are means 6 SEM.
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total cohort and showed that RLP-C concentrations at 3 h were
highly correlated with 6-h values. Although this indicates that
our postprandial model reflects conditions after a 6-h postpran-
dial period, it remains a limitation of this study that we could
not measure RLP-C accumulation over the total postprandial
period.
To detect disturbances in lipid metabolism, a pure high-fat
load was administered as a metabolic stressor. We acknowledge
that the very slight insulin response after this high-fat load may
have induced slightly different postprandial lipid responses in
this study compared with, e.g., a high-fat mixed meal. Despite
this, we observed similar associations between plasma RLP-C
and HOMAIR, WHR, and plasma TG concentrations to those
shown previously (10,11).
We observed a small positive association between habitual
physical activity and fasting RLP-C, which is not consistent with
earlier findings about the relationship between total physi-
cal activity and plasma lipoprotein concentrations (12,28,29).
The underlying mechanisms for this association remain to be
elucidated.
Weight loss improved fasting RLP-C concentrations, even after
correction for age, gender, and changes in HOMAIR and WHR,
showing that weight loss per se can be an appropriate tool to
improve fasting and postprandial RLP concentrations (30).
Furthermore, weight loss was comparable after both diets,
indicating that it was not the macronutrient composition of the
diet that influenced a reduction in body weight but the total
energy intake, because both diets were designed to provide 2510
kJ/d less than the individually estimated daily energy require-
ment (18). Therefore, it is interesting that despite a similar
weight loss, a high-fat diet leads to a better improvement in both
FIGURE 2 Postprandial plasma RLP-C concentrations (3 h) accord-
ing to WHR and HOMAIR quartiles. Quartile 1 corresponds to the
lowest WHR and HOMAIR values and quartile 4 to the highest values.
Values are means.
TABLE 3 Determinants of fasting plasma RLP-C in multiple
regression analyses1
Model 12 Model 22
n ¼ 740 b P-value b P-value
(Constant) ,0.001 ,0.001
Gender, male vs. female 0.156 ,0.001 0.109 0.001
BMI, kg/m2 0.041 0.315 0.082 0.008
Age, y 0.096 0.007 0.042 0.102
HOMAIR 0.235 ,0.001 20.029 0.326
WHR 0.157 0.004 0.011 0.781
Dietary fat intake, % energy 0.027 0.463 0.030 0.266
Total physical activity, AU 0.085 0.012 0.074 0.003
Plasma TG (fasting), mmol/L — — 0.712 ,0.001
Plasma FFA (fasting), mmol/L — — 20.020 0.474
Plasma HDL-C (fasting), mmol/L — — 20.001 0.985
1 The dependent is fasting plasma RLP-C in mmol/L. For statistical analyses, the
dependent variable was ln-transformed. —, variable not included in model 1.
2 Both models include the indicated variables in addition to center. Model 1 adj. R 2 ¼
0.23, model 2 adj. R 2 ¼ 0.60.
TABLE 4 Determinants of postprandial plasma RLP-C after a
high-fat meal containing 95en% fat1
Model 12 Model 22
n ¼ 712 b P-value b P-value
(Constant) ,0.001 ,0.001
Gender, male vs. female 0.041 0.156 0.029 0.269
BMI, kg/m2 0.028 0.288 0.032 0.185
Age, y 0.052 0.023 0.036 0.079
HOMAIR 0.104 ,0.001 0.026 0.274
WHR 0.142 ,0.001 0.100 0.002
Dietary fat intake, % energy 0.025 0.307 0.009 0.685
Total physical activity, AU 0.040 0.067 0.018 0.358
Plasma RLP-C (fasting),mmol/L 0.669 ,0.001 0.599 ,0.001
Plasma TG iAUC, mmol/L180
min
— — 0.278 ,0.001
Plasma FFA iAUC mmol/L180
min
— — 0.045 0.022
PlasmaHDL-C iAUC,mmol/L180
min
— — 20.031 0.109
1 The dependent is 3-h plasma RLP-C in mmol/L. For statistical analyses, the
dependent variable was ln-transformed. —, variable not included in model 1.
2 Both models include the indicated variables in addition to center and the energy% fat
meal of measured basal metabolic rate. Model 1 adj. R 2 ¼ 0.70, model 2 adj. R 2 ¼
0.76.
FIGURE 3 Strong relationship between the postprandial response
of plasma TG (iAUC) and plasma RLP-C (3 h) after a high-fat meal.
rs and P are shown in the figure.
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fasting RLP-C concentrations and fasting TG concentrations
than a low-fat diet in obese participants. This observation extends
the results of Abbasi et al. (16), showing that in healthy par-
ticipants, both fasting and postprandial RLP-C concentrations
are significantly lower after a high-fat diet than after a low-fat diet
and may be explained by the higher carbohydrate content of the
low-fat diet compared with the high-fat diet. It has been described
previously for the total NUGENOB cohort that the beneficial
effects of the dietary intervention on plasma TG, LDL-C, and
total cholesterol were mainly the result of weight loss per se, with
additional effects of diet composition (18).
Furthermore, improvements in insulin resistance were also
significantly related to a decrease in fasting RLP-C, independent
of weight loss. Again, after inclusion of fasting TG in the model,
these effects disappeared and only weight loss and a decrease in
fasting TG were associated with decreased plasma RLP-C,
emphasizing the outcomes of the baseline fasting and postpran-
dial models.
In summary, this multicenter study demonstrates that plasma
RLP-C concentrations are related to body fat distribution (WHR)
and the degree of insulin resistance (HOMAIR), both fasting and
3 h postprandial after a high-fat load. However, taking other
plasma lipid concentrations into account, plasma TG appeared to
be a strong determinant of plasma RLP-C.
The present mode of dietary intervention shows that, in-
dependent of weight loss, a high-fat diet is more effective in
lowering fasting plasma RLP-C concentrations in obesity than a
low-fat diet.
Literature Cited
1. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin
Invest. 2000;106:453–8.
2. Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ. Elevated
remnant-like particle cholesterol concentration: a characteristic feature of
the atherogenic lipoprotein phenotype. Circulation. 2004;109:1918–25.
3. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipide-
mia, and triglyceride-rich remnant lipoproteins. Clin Chem. 1995;41:
153–8.
4. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW,
Ordovas JM, Schaefer EJ. Remnant-like particle (RLP) cholesterol is an
independent cardiovascular disease risk factor in women: results from
the Framingham Heart Study. Atherosclerosis. 2001;154:229–36.
5. Karpe F, Boquist S, Tang R, Bond GM, de Faire U, Hamsten A.
Remnant lipoproteins are related to intima-media thickness of the
carotid artery independently of LDL cholesterol and plasma triglycer-
ides. J Lipid Res. 2001;42:17–21.
6. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting
triglycerides and risk of myocardial infarction, ischemic heart disease,
and death in men and women. JAMA. 2007;298:299–308.
7. Choi YJ, Jo YE, Kim YK, Ahn SM, Jung SH, Kim HJ, Chung YS, Lee KW,
Kim DJ. High plasma concentration of remnant lipoprotein cholesterol in
obese children and adolescents. Diabetes Care. 2006;29:2305–10.
8. Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda
N, Kurimoto Y, Yamada S, Ishikawa Y. Elevated remnant-like lipopro-
tein particles in impaired glucose tolerance and type 2 diabetic patients.
Diabetes Care. 1999;22:152–6.
9. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, Takeuchi H,
Shimamoto K. Relationship between insulin-resistance and remnant-
like particle cholesterol. Atherosclerosis. 2002;164:167–70.
10. Chan DC, Watts GF, Barrett PH, Mamo JC, Redgrave TG. Markers of
triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
Clin Chem. 2002;48:278–83.
11. Funada J, Sekiya M, Otani T, Watanabe K, Sato M, Akutsu H. The close
relationship between postprandial remnant metabolism and insulin
resistance. Atherosclerosis. 2004;172:151–4.
12. Imke C, Rodriguez BL, Grove JS, McNamara JR, Waslien C, Katz AR,
Willcox B, Yano K, Curb JD. Are remnant-like particles independent
predictors of coronary heart disease incidence? The Honolulu Heart
study. Arterioscler Thromb Vasc Biol. 2005;25:1718–22.
13. Mekki N, Christofilis MA, Charbonnier M, Atlan-Gepner C, Defoort C,
Juhel C, Borel P, Portugal H, Pauli AM, et al. Influence of obesity and
body fat distribution on postprandial lipemia and triglyceride-rich
lipoproteins in adult women. J Clin Endocrinol Metab. 1999;84:184–91.
14. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW,
Ordovas JM, Schaefer EJ. Remnant lipoprotein cholesterol and triglyc-
eride reference ranges from the Framingham Heart Study. Clin Chem.
1998;44:1224–32.
15. Ai M, Tanaka A, Ogita K, Sekinc M, Numano F, Numano F, Reaven
GM. Relationship between plasma insulin concentration and plasma
remnant lipoprotein response to an oral fat load in patients with type 2
diabetes. J Am Coll Cardiol. 2001;38:1628–32.
16. Abbasi F, McLaughlin T, Lamendola C, Kim HS, Tanaka A, Wang T,
Nakajima K, Reaven GM. High carbohydrate diets, triglyceride-rich
lipoproteins, and coronary heart disease risk. Am J Cardiol. 2000;85:
45–8.
17. Astrup A, Grunwald GK, Melanson EL, Saris WH, Hill JO. The role of
low-fat diets in body weight control: a meta-analysis of ad libitum
dietary intervention studies. Int J Obes Relat Metab Disord. 2000;24:
1545–52.
18. Petersen M, Taylor MA, Saris WH, Verdich C, Toubro S, Macdonald I,
Rossner S, Stich V, Guy-Grand B, et al. Randomized, multi-center trial
of two hypo-energetic diets in obese subjects: high- versus low-fat
content. Int J Obes (Lond). 2006;30:552–60.
19. Energy and protein requirements. Report of a joint FAO/WHO/UNU
Expert Consultation. World Health Organ Tech Rep Ser. 1985;724:
1–206.
20. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M,
Tanaka A, Tada N, Nakamura H, et al. Cholesterol in remnant-like
lipoproteins in human serum using monoclonal anti apo B-100 and anti
apo A-I immunoaffinity mixed gels. Clin Chim Acta. 1993;223:53–71.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF,
Turner RC. Homeostasis model assessment: insulin resistance and beta-
cell function from fasting plasma glucose and insulin concentrations in
man. Diabetologia. 1985;28:412–9.
22. Philippaerts RM, Westerterp KR, Lefevre J. Doubly labelled water
validation of three physical activity questionnaires. Int J Sports Med.
1999;20:284–9.
23. Montoye HJ, Kemper HCG, Saris WHM, Washburn RA. Measuring
physical activity and energy expenditure. Champaign (IL): Human
Kinetics; 1996.
24. Satoh A, Adachi H, Tsuruta M, Hirai Y, Hiratsuka A, Enomoto M, Furuki
K, Hino A, Takeuchi T, et al. High plasma level of remnant-like particle
cholesterol in the metabolic syndrome. Diabetes Care. 2005;28:2514–8.
TABLE 5 Determinants of changes in fasting plasma RLP-C
after a 10-wk hypo-energetic diet containing either
20–25 or 40–45en% fat1
Model 12 Model 22
n ¼ 613 b P-value b P-value
(Constant) 0.615 0.520
Gender, male vs. female 20.042 0.384 0.046 0.273
Diet, high vs. low fat 20.075 0.030 20.006 0.841
Age, y 20.053 0.157 20.004 0.905
D Weight,3 kg 0.240 ,0.001 0.149 ,0.001
D HOMAIR 0.121 0.001 0.051 0.104
D WHR 20.007 0.847 20.012 0.683
D Plasma TG (fasting), mmol/L — — 0.534 ,0.001
D Plasma FFA (fasting), mmol/L — — 0.054 0.078
D Plasma HDL-C (fasting), mmol/L — — 20.018 0.598
1 The dependent is the change in fasting plasma RLP-C in mmol/L. For statistical
analyses, the dependent variable was ln-transformed. —, variable not included in
model 1.
2 Both models include the indicated variables in addition to center and the mean values
(10 wk 1 0 wk) / 2) of each change variable. Model 1 adj. R2 ¼ 0.29, model 2 adj. R2 ¼
0.51.
3 The change (D) of each variable was calculated as (10 wk – 0 wk).
2404 van Hees et al.







25. Abbasi F, McLaughlin T, Lamendola C, Yeni-Komshian H, Tanaka A,
Wang T, Nakajima K, Reaven GM. Fasting remnant lipoprotein choles-
terol and triglyceride concentrations are elevated in nondiabetic, insulin-
resistant, female volunteers. J Clin Endocrinol Metab. 1999;84:3903–6.
26. Schaefer EJ, McNamara JR, Shah PK, Nakajima K, Cupples LA, Ordovas
JM, Wilson PW. Elevated remnant-like particle cholesterol and triglycer-
ide levels in diabetic men and women in the Framingham Offspring Study.
Diabetes Care. 2002;25:989–94.
27. Couillard C, Bergeron N, Pascot A, Almeras N, Bergeron J, Tremblay A,
Prud’homme D, Despres JP. Evidence for impaired lipolysis in abdom-
inally obese men: postprandial study of apolipoprotein B-48- and
B-100-containing lipoproteins. Am J Clin Nutr. 2002;76:311–8.
28. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB,
McCartney JS, Bales CW, Henes S, Samsa GP, et al. Effects of the
amount and intensity of exercise on plasma lipoproteins. N Engl J Med.
2002;347:1483–92.
29. O’Donovan G, Owen A, Kearney EM, Jones DW, Nevill AM, Woolf-
May K, Bird SR. Cardiovascular disease risk factors in habitual
exercisers, lean sedentary men and abdominally obese sedentary men.
Int J Obes (Lond). 2005;29:1063–9.
30. Dallongeville J, Gruson E, Dallinga-Thie G, Pigeyre M, Gomila S,
Romon M. Effect of weight loss on the postprandial response to high-fat
and high-carbohydrate meals in obese women. Eur J Clin Nutr. 2007;
61:711–8.
Determinants of remnant-like particle cholesterol 2405
 by guest on M
arch 30, 2013
jn.nutrition.org
D
ow
nloaded from
 
